ROME Therapeutics

📍 Cambridge, United States🗓 Founded 2020👥 17 employees
Biotechnology🌐 rometx.com
Website LinkedIn
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.” With several drug targets identified and multiple discovery programs underway, ROME is moving rapidly to leverage this new frontier in biology. To lead this exploration, ROME has assembled a team of world-class leaders across fields including oncology, immunology, virology and machine learning. ROME was launched in April 2020 and was incubated at GV, in collaboration with ARCH Venture Partners and Partners Innovation Fund. ROME is based in Cambridge, Mass. For more information, please visit www.rometx.com.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was ROME Therapeutics founded?
ROME Therapeutics was founded in 2020.
What industry is ROME Therapeutics in?
ROME Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is ROME Therapeutics based?
ROME Therapeutics is headquartered in Cambridge, United States.